Journey Medical Corporation announced the appointment of Joseph M. Benesch as Chief Financial Officer, effective April 26, 2024. Mr. Benesch had served as the company?s Interim Chief Financial Officer since January 2023 and he served as the company?s corporate controller prior to that since November 2021. Mr. Benesch has over 25 years of experience in all aspects of corporate financial leadership and reporting, technical accounting and controls, corporate controllership, regulatory and public company compliance, treasury and pharmaceutical company operations.

Prior to joining Journey Medical, Mr. Benesch previously served as the Principal Accounting Officer, Vice President and Corporate Controller of Teligent Pharma Inc. and Corporate Controller of Torrent Pharmaceuticals. Before joining Torrent, he held senior financial management positions of increasing responsibility from Corporate Controller to Vice President of Finance at Savient Pharmaceuticals, Adare Pharmaceuticals and Edenbridge Pharmaceuticals. Mr. Benesch began his career in the public accounting sector at Baker Tilly Virchow Krause, LLP, and Ernst and Young working with a diverse client base.

Mr. Benesch is a graduate of Wilkes University where he earned a BA in accounting and is a Certified Public Accountant.